Islet Cell Antibody

Islet Cell Antibody (ICA)

What it is

The Islet Cell Antibody (ICA) test detects autoantibodies that target the insulin-producing beta cells of the pancreas. These antibodies are commonly found in individuals with type 1 diabetes and may appear months or years before the disease develops. The test is a valuable tool for identifying autoimmune activity against the pancreas.

Uses

This test is used to help diagnose type 1 diabetes, assess the risk of developing type 1 diabetes in at-risk individuals, and differentiate type 1 from type 2 diabetes in unclear cases. It may also be part of a panel of autoimmune diabetes tests, including GAD, IA-2, and insulin autoantibodies.

Symptoms That May Lead to the Test

Doctors may recommend this test if you show symptoms of diabetes such as excessive thirst, frequent urination, unexplained weight loss, fatigue, or blurred vision. It may also be ordered if you have a family history of type 1 diabetes or other autoimmune conditions that increase risk.

Abnormal Results

Positive ICA: Indicates autoimmune activity against pancreatic beta cells and a higher likelihood of type 1 diabetes, either current or future. Multiple positive autoantibodies further increase the risk.

Negative ICA: Suggests no detectable islet cell autoimmunity at the time of testing. However, absence of antibodies does not fully rule out type 1 diabetes if symptoms and other markers are present.

Risks

The test requires a simple blood draw, with minimal risks such as slight pain, bruising, or dizziness at the puncture site. Serious complications are very rare.